Filter
643
Filtered Results: 643
Text search:
nucleic
Acid
Featured
Recommendations
111
New Publications
158
Language
Document type
No document type
320
Guidelines
159
Studies & Reports
83
Manuals
44
Fact sheets
18
Training Material
6
Strategic & Response Plan
6
Situation Updates
3
Infographics
2
Resource Platforms
1
Videos
1
Countries / Regions
India
42
Western and Central Europe
19
Global
17
Tanzania
12
South Africa
11
Eastern Europe
11
Africa
10
Latin America and the Carribbean
9
Ethiopia
9
Brazil
8
Nigeria
7
Nepal
6
Kenya
6
Liberia
6
Rwanda
5
Peru
5
East and Southern Africa
5
Bangladesh
5
Zambia
5
Myanmar / Burma
5
Ukraine
4
Asia
4
Congo, Democratic Republic of
4
West and Central Africa
4
Eastern Europe and Central Asia
4
Russia
4
Angola
4
Colombia
3
El Salvador
3
Sierra Leone
3
Senegal
3
Germany
3
Argentina
3
Uganda
3
Namibia
3
China
2
Cameroon
2
Syria
2
Philippines
2
Guinea
2
Mozambique
2
Middle East and North Africa
2
South–East Asia Region
2
Portugal
2
Vietnam
2
Pakistan
2
Timor Leste/ East Timor
1
Lesotho
1
Turkey
1
Ghana
1
Burkina Faso
1
Afghanistan
1
Italy
1
USA
1
Haiti
1
Cambodia
1
Western Pacific Region
1
Uruguay
1
France
1
United Kingdom
1
Spain
1
Côte d’Ivoire / Ivory Coast
1
Moldova
1
Sri Lanka
1
Georgia
1
Chad
1
Bhutan
1
Botswana
1
South Sudan
1
Indonesia
1
Authors & Publishers
Publication Years
Category
Countries
163
Clinical Guidelines
113
Pharmacy & Technologies
46
Public Health
19
Key Resources
18
Women & Child Health
14
Capacity Building
4
Toolboxes
TB
128
COVID-19
112
HIV
75
NTDs
49
Rapid Response
44
Ebola & Marburg
23
Zika
17
AMR
15
Refugee
13
Pharmacy
12
Polio
6
Mental Health
4
Specific Hazards
4
Caregiver
4
Planetary Health
4
Conflict
3
Natural Hazards
2
Health Financing Toolbox
2
NCDs
2
Global Health Education
1
Interim Assessement Report
The EMA review was started by the Agency’s Committee for Medicinal Products for Human Use (CHMP) to support decision-making by health authorities. This first interim report includes information on seven experimental medicines intended for the treatment of people infecte...
Hepatitis B (HBV) infection is a major public health problem and cause of chronic liver disease.
The 2024 HBV guidelines provide updated evidence-informed recommendations on key priority topics. These include expanded and simplified treatment criteria for adults but now also for adolescents; expa...
The Democratic Republic of Timor-Leste has the highest TB incidence rate in the South East Asian Region - 498 per 100,000, which is the seventh highest in the world. In Timor-Leste TB is the eighth most common cause of death.
The salient observations are as follows:
In 2018, 487 (12.5%) of the...
Le défi des pays en voie de développement est la disponibilité de méthodes de diagnostic rapide et précis pour le management de la tuberculose. Des techniques moléculaires offrent cet avantage et nous avons utilisé le test GeneXpert MTB/RIF dans le diagnostic de la tuberculose extra-pulmonair...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or for being at 1 of the 3 levels of achievement on the ‘Path to Elimination...
В дорожной карте по борьбе с забытыми тропическими болезнями на 2021–2030 гг. («дорожная карта») определены глобальные цели и основные этапы в отношении борьбы с 20 бол...
Tuberculosis Infection Control Guidelines
recommended
Second Edition
These guidelines aim to guide all health care providers in Myanmar, accommodating the situation of different settings in the context of progressive decentralization of HIV services. Notable changes from the previous edition include:
• diagnosis of HIV
• update on the initiation of ART<...
• diagnosis of HIV
• update on the initiation of ART<...
This 2011 update of Guidelines for the programmatic management of drug-resistant tuberculosis is intended as a tool for use by public health professionals working in response
to the Sixty-second World Health Assembly’s resolution on prevention and control of multidrug-resistant tuberculosis and e...
2nd edition
6 June 2022
These WHO interim recommendations on the use of the Janssen Ad26.COV2.S (COVID-19) vaccine were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
Th...
TB remains one of the world’s deadliest infectious diseases, second only to COVID-19, and drug-resistant TB strains are still a major concern. In the fight against TB, urgent investment is critical, especially in the context of the ongoing pandemic.
Meeting Report
27–30 June 2017 Manila, Philippines
Rutstein SE et al. Journal of the International AIDS Society 2017, 20:21579 http://www.jiasociety.org/index.php/jias/article/view/21579 | http://dx.doi.org/10.7448/IAS.20.1.21579
Updated guidance. The guidance provides useful information to staff working in prisons, as well as to health and prison authorities, explaining how to prevent and address a potential outbreak of COVID-19. In addition, it aims to protect the health and well-being of all those who live and work in, an...
The road map sets global targets and milestones to prevent, control, eliminate or eradicate 20 diseases and disease groups as well as cross-cutting targets aligned with the Sustainable Development Goals. Three foundational pillars will support global efforts to achieve the targets: accelerate progra...
